Events

Hycult Biotech

Upcoming Events 2024

Hycult Biotech regularly participates in, organizes, and supports various congresses. We believe it is crucial to keep up-to-date of the latest advancements in life science and to engage with all stakeholders involved. These events provide us with opportunities to both gain and share knowledge to help improve drug development and in particular complement research. If your research focuses on innate immunity, we would be delighted to connect with you!

DateEvent Place
5th – 8th February, 2024Medlab Middle EastDubai
3rd – 7th May, 2024AAIChicago, IL, United States
11th – 16th June, 202416th International Conference on Complement TherapeuticsLoutraki, Greece
17th – 18th June, 2024Pivotal LinksOxford, United Kingdom
28th July – 1st August, 2024ADLMChicago, IL, United States
2nd – 6th September , 202419th European Meeting on Complement in Human DiseasesLübeck, Germany
13th – 16th November, 2024MEDICA Düsseldorf, Germany
10th – 12th December, 2024Complement-Based Drug Development SummitBoston, MA, United States

Feel free to contact us and we can schedule a time & date! Send us an email: info@hycultbiotech.com or fill in our contact form.

Other interesting posts
New ELISAs for Factor H-related proteins

We are happy to introduce to you our new ELISA kits developed to detect human Factor H-related proteins (FHR-2, FHR-3, FHR-4 and FHR-5). The kits were co-developed within the SciFiMed project, a European multi-disciplinary consortium that includes Hycult Biotech and Sanquin...
NHP cells seen from under microscope, lab technician performing on complement ELISA and happy lady looking at air balloons
Discover Cross-Reactive Complement ELISA for NHP Research

Bridging Human and NHP Complement Research. At Hycult Biotech, we understand the importance of testing therapeutic agents on non-human primates (NHP) samples in order to get approval to enter clinical phases. That is why we have committed to the following...
New Human Complement Pathway Assays

We are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to...
More posts
Contact us